Literature DB >> 9988595

Studies to establish quality control ranges for SB-265805 (LB2030) when using National Committee for Laboratory Standards antimicrobial susceptibility test methods. Quality Control Study Group.

M E Erwin, R N Jones.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 9988595      PMCID： PMC84241     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  2 in total

1.  In vitro and in vivo evaluations of LB20304, a new fluoronaphthyridone.

Authors:  J I Oh; K S Paek; M J Ahn; M Y Kim; C Y Hong; I C Kim; J H Kwak
Journal:  Antimicrob Agents Chemother       Date:  1996-06       Impact factor: 5.191

2.  Antimicrobial activity and spectrum of LB20304, a novel fluoronaphthyridone.

Authors:  M G Cormican; R N Jones
Journal:  Antimicrob Agents Chemother       Date:  1997-01       Impact factor: 5.191
  2 in total
  3 in total

1.  Differential effect of P-gp and MRP2 on cellular translocation of gemifloxacin.

Authors:  Ramya Krishna Vadlapatla; Aswani Dutt Vadlapudi; Deep Kwatra; Dhananjay Pal; Ashim K Mitra
Journal:  Int J Pharm       Date:  2011-08-16       Impact factor: 5.875

2.  Pharmacokinetics and tolerability of gemifloxacin (SB-265805) after administration of single oral doses to healthy volunteers.

Authors:  A Allen; E Bygate; S Oliver; M Johnson; C Ward; A J Cheon; Y S Choo; I C Kim
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

3.  Intracellular penetration and activity of gemifloxacin in human polymorphonuclear leukocytes.

Authors:  I García; A Pascual; S Ballesta; P Joyanes; E J Perea
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.